Supplementary Material-Safety and clinical response of TNF-α inhibitor adalimumab in the treatment of severe acne: A real-world study

Published: 19 January 2026| Version 1 | DOI: 10.17632/fyrcnvnp5y.1
Contributors:
Zhuokun Liu, Xin Liu, Yufei Wu, Jialin Lian, Danyang Yang, Jiayi Han, Ruilian Li, Chenyue Liu, Xiaoli Li

Description

Supplementary Material for the paper "Safety and clinical response of TNF-α inhibitor adalimumab in the treatment of severe acne: A real-world study".

Files

Institutions

  • Xi'an Jiaotong University Second Affiliated Hospital
  • Xi'an Jiaotong University Medical College First Affiliated Hospital

Categories

Dermatology, Acne

Licence